Table 1.
Pre-transplantation
|
Perioperative
|
After transplantation
|
Hypovolemia; Infections; Nephrotoxic drugs; Hepatorenal syndrome; High MELD; NASH/MAFLD; Renal parenchymal diseases associated with hepatitis B, C and alcohol | Hemodynamic instability; Reperfusion injury; Nephrotoxic drugs | Calcineurin inhibitors; Diabetic nephropathy; Hypertensive nephropathy |
MELD: Model for end-stage liver disease; NASH: Non-alcoholic steatohepatitis; MAFLD: Metabolic dysfunction-associated fatty liver disease.